Adverse Events of Prostacyclin Mimetics in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis

Prostacyclin mimetics (PMs) are effective for the treatment of pulmonary arterial hypertension (PAH). However, their clinical use may be limited by their adverse events. This study aims to quantify the different PM adverse events (AEs) with regard to their selectivity towards the prostacyclin (IP) r...

Descripción completa

Detalles Bibliográficos
Autores principales: Picken, Christina, Fragkos, Konstantinos C., Eddama, Mohammad, Coghlan, Gerry, Clapp, Lucie H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517977/
https://www.ncbi.nlm.nih.gov/pubmed/30970653
http://dx.doi.org/10.3390/jcm8040481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517977/
https://www.ncbi.nlm.nih.gov/pubmed/30970653
http://dx.doi.org/10.3390/jcm8040481

Ejemplares similares